{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-24-000036","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.680044+00:00","generated_at":"2026-05-31T13:57:54.399117+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Sotera Health appoints Christopher A. Simon to board of directors","bullets":["Board increased from 11 to 12 directors; Simon appointed as Class III director effective August 1, 2024.","Simon is President & CEO of Haemonetics Corporation and will serve on the Leadership Development and Compensation Committee.","Simon is independent under Nasdaq Rule 5605(a)(2); no arrangement or reportable transactions with the company.","As non-employee director, Simon will receive standard cash retainer and annual restricted stock unit grant."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-24-000036","json":"https://secwatch.observer/filing/0001822479-24-000036.json","markdown":"https://secwatch.observer/filing/0001822479-24-000036.md","text":"https://secwatch.observer/filing/0001822479-24-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/0001822479-24-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/shc-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:57:54.399117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14f843f876","claim":"Christopher A. Simon was appointed as Class III director at Sotera Health Co.","evidence_excerpt":"On July 31, 2024, the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) increased the size of the Board from eleven directors to twelve directors and appointed Christopher A. Simon as a Class III director of the Board, effective August 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/0001822479-24-000036-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}